A2 Biotherapeutics

aid: a2-biotherapeutics
name: A2 Biotherapeutics
description: A2 Biotherapeutics (A2 Bio) is a clinical-stage biotechnology company headquartered in Agoura Hills, California,
  founded in 2018 by Alexander Kamb, Michael Gallo and Paul Kang. It develops logic-gated cell therapies for solid tumors
  on its proprietary Tmod platform, a two-receptor activator/blocker design that lets an engineered T cell attack tumor cells
  which have lost an HLA allele while sparing normal cells that retain it. A2 Bio operates no developer API programme and
  publishes no product, clinical or research API. It is catalogued here because its corporate website runs a live WordPress
  REST API with 298 discoverable routes, and because that same install exposes two Model Context Protocol servers guarded
  by an OAuth 2.1 authorization server the host advertises through RFC 8414 and RFC 9728 metadata.
image: https://www.a2bio.com/wp-content/uploads/A2-Bio-Email-Logo-200-x-200.jpg
url: https://raw.githubusercontent.com/api-evangelist/a2-biotherapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: enriched
x-tier-reason: enrichment pass 2026-08-02
specificationVersion: '0.20'
created: '2026-08-02'
modified: '2026-08-02'
tags:
- Company
- Biotechnology
- Life Sciences
- Cell Therapy
- Immuno-Oncology
- Oncology
- Pharmaceuticals
- Clinical Trials
- Healthcare
- Model Context Protocol
- WordPress
apis:
- name: A2 Biotherapeutics WordPress REST API
  description: The live WordPress REST API served by the A2 Biotherapeutics corporate website. Route discovery is anonymous
    and advertises 298 routes across 16 namespaces; published content under wp/v2 (posts, pages, media, taxonomies) is readable
    without credentials, while writes, the WordPress Abilities registry and the MCP namespace are gated. This is the content-management
    API of the marketing site, not a therapeutic or research API. The OpenAPI in this repo is derived by API Evangelist from
    the provider's own live route-discovery document; A2 Bio publishes no OpenAPI itself.
  humanURL: https://www.a2bio.com/wp-json/
  baseURL: https://www.a2bio.com/wp-json/
  tags:
  - WordPress
  - Content
  - Newsroom
  - Model Context Protocol
  properties:
  - type: OpenAPI
    url: openapi/a2-biotherapeutics-wp-rest-openapi.yml
  - type: Overlay
    url: overlays/a2-biotherapeutics-wp-rest-overlay.yaml
  - type: MCPServer
    url: mcp/a2-biotherapeutics-mcp.yml
  - type: ToolCrosswalk
    url: mcp/a2-biotherapeutics-tool-crosswalk.yml
  - type: DataModel
    url: data-model/a2-biotherapeutics-data-model.yml
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.a2bio.com/
- type: Newsroom
  url: https://www.a2bio.com/newsroom/
- type: Blog
  url: https://www.a2bio.com/newsroom/
- type: BlogRSS
  url: https://www.a2bio.com/feed/
- type: Careers
  url: https://www.a2bio.com/careers/
- type: Investors
  url: https://www.a2bio.com/about-us/investors/
- type: Contact
  url: https://www.a2bio.com/contact-us/
- type: TermsOfService
  url: https://www.a2bio.com/terms-of-use/
- type: PrivacyPolicy
  url: https://www.a2bio.com/privacy-policy/
- type: Compliance
  url: https://www.a2bio.com/california-compliance/
- type: SecondaryMarket
  url: https://forgeglobal.com/a2-biotherapeutics_stock/
- type: OpenAPI
  url: openapi/a2-biotherapeutics-wp-rest-openapi.yml
- type: Overlay
  url: overlays/a2-biotherapeutics-wp-rest-overlay.yaml
- type: MCPServer
  url: mcp/a2-biotherapeutics-mcp.yml
- type: ToolCrosswalk
  url: mcp/a2-biotherapeutics-tool-crosswalk.yml
- type: AgentSkill
  url: skills/_index.yml
- type: LLMsTxt
  url: llms/a2-biotherapeutics-llms.txt
- type: WellKnown
  url: well-known/a2-biotherapeutics-well-known.yml
- type: ContentSignal
  url: well-known/a2-biotherapeutics-robots.txt
- type: Authentication
  url: authentication/a2-biotherapeutics-authentication.yml
- type: OAuthScopes
  url: scopes/a2-biotherapeutics-scopes.yml
- type: Conventions
  url: conventions/a2-biotherapeutics-conventions.yml
- type: ErrorCatalog
  url: errors/a2-biotherapeutics-problem-types.yml
- type: DataModel
  url: data-model/a2-biotherapeutics-data-model.yml
- type: Lifecycle
  url: lifecycle/a2-biotherapeutics-lifecycle.yml
- type: Conformance
  url: conformance/a2-biotherapeutics-conformance.yml
- type: DomainSecurity
  url: security/a2-biotherapeutics-domain-security.yml
x-enrichment:
  date: '2026-08-02'
  status: enriched
  artifacts_added: 21
  pass: local-v1
x-enrichment-notes: 'Deliberately absent, each a verified negative on 2026-08-02: Idempotency (no idempotency contract exists
  on this surface), SDKs/Packages (nothing first-party on npm, PyPI or any registry), StatusPage (status.a2bio.com NXDOMAIN),
  Deprecation (no policy, no RFC 8594 headers), Security and SecurityTxt (/.well-known/security.txt 404, no disclosure page,
  no bug bounty), TrustCenter (trust.a2bio.com NXDOMAIN, no security certifications published), AgentCard (/.well-known/agent-card.json
  and /.well-known/agent.json both 404), AsyncAPI and Webhooks (no event surface), GitHubOrganization (github.com/A2Bio exists
  but carries no attribution to this company, so it is not claimed), Postman, Pricing, SignUp, Roadmap, Documentation, DeveloperPortal,
  APIReference, GettingStarted, Support, CLI, Sandbox and Components. The Compliance pointer is the company''s published pharmaceutical
  regulatory compliance declaration, not a security attestation.'